Researchers have developed a machine learning model that can predict chemotherapy-associated nephrotoxicity.
Nanoengineers plan to develop an immunotherapy for ovarian cancer using 3D-bioprinted plant virus nanoparticles.
Improving the prediction of survival indicators in patients with breast cancer using tools from artificial intelligence and probabilistic modelling is the aim of ModGraProDep.
Commercially available app-based technology now makes early detection of lymphedema easier, allowing for proactive treatment.
Using a robot to treat brain aneurysms is feasible and could allow for improved precision when placing stents, coils and other devices.
A novel method of combining advanced optical imaging with an artificial intelligence algorithm produces accurate, real-time intraoperative diagnosis of brain tumors.
Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma.
An AI has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.
A software tool uses artificial intelligence to recognize cancer cells from digital pathology images — giving clinicians a powerful way of predicting patient outcomes.
An AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.
Radiologists assisted by deep learning based software were better able to detect malignant lung cancers on chest X-rays.
Researchers show that deep learning algorithms perform similar to human experts when classifying blood samples from patients suffering from acute myeloid leukemia.
Using machine learning, researchers have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are likely to benefit from immunotherapy.
Researchers from Thomas Jefferson University use machine learning on ultrasound images of thyroid nodules to predict risk of malignancy.
An AI tool identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists.